Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Pure speculation.
View:
Post by alleyesonme on Sep 19, 2024 12:07pm

Pure speculation.

Close working relationship, obvious synergies, can't help but suspect a merger on the horizon with Avicanna. They also recently paid off debentures.
Comment by QContinuum1 on Sep 19, 2024 12:29pm
  Not interested.  Worry about growing the existing business and then take them out from a position of power.  
Comment by CADInvestor12 on Sep 19, 2024 3:31pm
Love the idea of merging/ acquiring with Avicanna .. don't see it happening without major dilution. 
Comment by okgonow on Sep 19, 2024 3:58pm
I would much prefer if Strada would take a run at us all cash deal at a decent premium and we would still be dirt cheap  I would vote yes if they showed up with a $.35 offer thats roughly $144mill for the whole thing thats Chicken feet to an outfit like Strada 
Comment by NoRiskNoReward on Sep 19, 2024 9:42pm
The only way I see a merger with avicanna without dilution is if Johnson & Johnson gets involved.  J&J buys a 49% stake in Labs at 3x sales value. Which would inject us with $60 million . Then we buy out avicanna at $40 million.  then we have a company that does $70 million in sales with $30 million in the bank, and is pharma ready for epidiolex.  https://www.nasdaq ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities